What is Glow?
Founded by a team of technology veterans, including Max Levchin, Glow operates at the forefront of the digital health sector. The company utilizes sophisticated data science to provide users with actionable insights into reproductive health, spanning from fertility tracking to pregnancy support. By launching a suite of specialized applications—including the flagship Glow app, Glow Nurture, and Eve by Glow—the company has established a comprehensive ecosystem that captures longitudinal health data. This market position allows Glow to not only serve individual users but also to contribute meaningful scientific discoveries to the broader medical community, effectively bridging the gap between consumer-facing health tools and clinical research.
How much funding has Glow raised?
Glow has raised a total of $23M across 2 funding rounds:
Series A
$6M
Series B
$17M
Series A (2013): $6M with participation from Andreessen Horowitz and Founders Fund
Series B (2014): $17M led by Andreessen Horowitz, Formation8, and Founders Fund
Key Investors in Glow
Andreessen Horowitz
A prominent venture capital firm that invests in bold entrepreneurs building the future through technology, with a deep focus on software and healthcare innovation.
Formation8
A venture capital firm that supports top entrepreneurs in building market-leading smart enterprise and energy technology companies by providing operational expertise.
Founders Fund
A venture capital firm that invests in the world's most important and valuable companies across all geographies, sectors, and stages, known for its founder-friendly investment strategy.
What's next for Glow?
With the support of its latest financing, Glow is poised to scale its enterprise-level operations and deepen its research capabilities. The strategic focus will likely shift toward expanding its data infrastructure to support larger clinical studies and enhancing the predictive accuracy of its health algorithms. As the company matures, it is expected to explore further integration with healthcare providers and insurance platforms, aiming to transform its vast repository of reproductive health data into a standard for personalized medical care. By maintaining its founder-led vision and leveraging its strong investor backing, Glow is well-positioned to navigate the complexities of the digital health landscape and drive long-term value in the reproductive health sector.
See full Glow company page
